Impact of Covid-19 on the management of patients with metastatic melanomaArticle Published on 2022-12-292023-07-11 Journal: Oncotarget [Category] COVID19(2023년), [키워드] COVID-19 Immunotherapy metastatic melanoma SARS-CoV-2 targeted therapy [DOI] 10.18632/oncotarget.28333 PMC 바로가기
Factors influencing the SARS-CoV-2 infection and vaccination induced immune response in rheumatoid arthritisArticle Published on 2022-10-122022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, 치료기술, 치료제, [키워드] addition age anti-CD20 therapy anti-S anti-S antibody anti-SARS-CoV-2 antibodies antibody Antibody Response BNT162b2 cell-mediated response Cellular immune response cellular immune responses ChAdOx1 Concentration Corona covariate adjustment COVID-19 COVID-19 vaccine declined dependent on DMARD (disease-modifying antirheumatic drug treatment) domains dose enrolled Factor healthy controls humoral IL-6 inhibitor immune response Infection inhibited investigated IQR magnitude median time mRNA-1273 Patient patients patients treated peptides positive patient reduced respiratory rheumatoid arthritis RNA RNA vaccine SARS-CoV-2 significant effect significantly Specific specific antibodies specific antibody subject T-cell T-cell Response targeted therapy the healthy the interferon the SARS-CoV-2 the vaccine therapy vaccination Vaccine variables was measured were infected [DOI] 10.3389/fimmu.2022.960001 PMC 바로가기
Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanismArticle Published on 2022-10-102022-11-15 Journal: Molecular Medicine [Category] 바이오마커, [키워드] Accuracy acute COVID-19 Angiogenesis AUC Biomarker Biomarkers Blood case-control study characterized Cohort COVID-19 Diagnosis diagnostics disease elevated Endoglin female Follow-up Health healthy control ICAM-1 immunoassay Inpatient Intervention investigated lack long-COVID machine machine learning marker median multiplex outpatients pathophysiological mechanism Patient patients Post-infection Sensitivity and specificity Sex significantly Specific subject Symptom targeted therapy therapeutic efficacy unique Vascular Vascular transformation. vasculature VCAM-1 VLA-4 [DOI] 10.1186/s10020-022-00548-8 PMC 바로가기
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19Research article Published on 2022-10-012022-10-05 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), SARS, 바이오마커, 변종, 유전자 메커니즘, 임상, 진단, 치료기술, [키워드] 95% CI Activation adjusted adjusted odds ratio aggregation Alpha Analysis application B.1.1.7 Bath biochemical Biomarkers biomarkers of inflammation biopsy changes clinical factors clinical outcomes clinically Coagulation Cohort Complication correlation Council COVID-19 death develop Dexamethasone diagnostic Direct driving dysregulation of coagulation Engineering evaluated facilitate finding foundation funding hazard ratio heart hospital identify in-hospital mortality indicated Inflammation investigated mammary marker myocardial injury National Health Service NHS NIHR Non-invasive outcome Oxford parameters Pathways Patient patients with COVID-19 perivascular Platelet platform predict produced Prognostic value pulmonary angiography pulmonary CT representing respond responsible risk RNA sequencing data SARS-CoV-2 variant Science sensitivity analysis targeted therapy therapeutic target transcriptional transcriptomic Treatment Trial validation study variant vascular inflammation Wellcome Trust Whole blood wild-type SARS-CoV-2 with COVID-19 [DOI] 10.1016/S2589-7500(22)00132-7 [Article Type] Research article
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccineReview article Published on 2022-10-012022-10-05 Journal: International immunopharmacology [Category] COVID19(2023년), SARS, 변종, 임상, 치료제, [키워드] acute respiratory syndrome affected antiviral agent approach approved caused Cell Cell based therapy characterized coronavirus coronavirus 2 Coronavirus disease 2019 Corticosteroids COVID-19 drug evaluated Gene therapy high risk highly pathogenic immune Immunotherapy in vitro in vivo Inflammatory Medical conditions modulating outcomes Oxygen therapy Patient Population SARS-CoV-2 syndrome targeted therapy therapeutic option therapy thrombosis Treatment Vaccine variety Vascular injury virus [DOI] 10.1016/j.intimp.2022.109161 [Article Type] Review article
Impaired serological response to COVID-19 vaccination following anticancer therapy: A systematic review and meta-analysis항암 치료 후 코로나19 백신 접종에 따른 혈청학적 반응 저하: 체계적 고찰 및 메타분석Meta-Analysis Published on 2022-10-012022-09-12 Journal: Journal of medical virology [Category] Fulltext, MERS, 진단, [키워드] 95% confidence interval Affect anti-CD20 antibody anticancer association B-cell lymphoma Cancer cellular response Chemotherapy conducted coronavirus disease correlated COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines demonstrated dose evaluate Fatality rate hormonal therapy humoral immune response Immunotherapy Impaired inhibitor Meta-analysis morbidity Odds ratio Patient patients Patients with cancer postvaccination Research response to vaccination risk Seroconversion seroconversion rate serological serological response significantly significantly lower subgroup analysis suggested systematic review targeted therapy therapy Treatment tyrosine vaccination Vaccination strategy Vaccine [DOI] 10.1002/jmv.27956 PMC 바로가기 [Article Type] Meta-Analysis
Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: A cohort study and a meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Joint bone spine [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome addition Antibody Response biologic Cohort cohort study conducted coronavirus COVID-19 COVID-19 pandemic disease evaluated identify IgG antibody immune-mediated diseases impair individuals Inflammatory Inflammatory rheumatic diseases IQR leflunomide less management median age Meta-analysis methotrexate observational study Older participant Patient performed Prevalence reported rheumatic disease rituximab robust Sample size SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV2 vaccination second vaccination seroconversion rate seroconverted serological response significantly Spike protein suggested targeted therapy Therapies therapy treated two-dose regimen vaccination Vaccine were measured [DOI] 10.1016/j.jbspin.2022.105380 PMC 바로가기
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritidesArticle Published on 2022-10-012022-11-15 Journal: Joint bone spine [Category] 진단, [키워드] Abstract anti-cytokine therapy anti-SARS-CoV-2 arthritide bDMARDs. COVID-19 Inflammatory Patient serology T-cell targeted therapy vaccination vaccine response [DOI] 10.1016/j.jbspin.2022.105391 PMC 바로가기
Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in IndiaArticle Published on 2022-09-222022-11-15 Journal: PLoS ONE [Category] 진단, [키워드] approach assessment carried conducted COVID-19 COVID-19 pandemic COVID-19 testing diagnostic diagnostic test diagnostics evaluate External Guidance healthcare service Impact India Interpretation involved Laboratory lockdown management measure molecular offer offered pandemic participant Participants Precaution Precision Program Quality quality check Registered required resource solid tumor solid tumour Surveillance targeted therapy utility [DOI] 10.1371/journal.pone.0274089 PMC 바로가기
Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19Article Published on 2022-09-212022-11-16 Journal: Cells [Category] SARS, 변종, 유전자 메커니즘, [키워드] accompanied accompany adaptive B.1.617 Blood caused Characteristics contribute coronavirus disease correlated COVID-19 COVID-19 pathogenesis Cytokine storm Delta delta variant diagnostic dominant Factor Gene Expression gene expression signature high mortality highlight immune immune component immune response immune system Immunity immunological individual Infection Lineage lymphoid molecular monocyte Monocytes mononuclear cell Multiple myeloid cells pathway performed proinflammatory required Revealed risk SARS-CoV-2 SARS-CoV-2 lineage severity signature significant changes in single-cell syndrome targeted therapy therapeutic Transcriptome understanding variant virus with COVID-19 [DOI] 10.3390/cells11192950 PMC 바로가기